ATII · Archimedes Tech SPAC Partners II Co.
$7.17
-1.38 (-16.09%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with the Company's assessment of going concern considerations in accordance with FASB ASC 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that the Company currently lacks the liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the unaudited condensed consolidated financial statements are issued as it expects to continue to incur significant costs in pursuit of its acquisition plans. In addition, if the Company is unable to complete an initial business combination by November 12, 2026, then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution and liquidity concerns raise substantial doubt about the Company's ability to continue as a going concern. Management plans to consummate an initial business combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after November 12, 2026.”View the 10-Q filed Aug 13, 2026
Market Cap
$221.04M
Shares
29.59M
Volume · Oct 20
93.2K
Avg daily vol (3M)
258.12K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.17
Open$8.45
Day$6.63–8.88
52W close$7.17–11.38
Avg vol 30d376K
Short int18K · 0.1% float · 1.0d
Short vol51%
Last earningsApr 28, 2026
DataApr 2025–Oct 2026
Filing10-Q · Aug 13
Up next
filed Aug 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$130.58M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$414,970
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
-30.7%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Moderate
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−33%
below
Price vs 50-day avg
−32%
below
RSI (14)
11
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−33%
trailing
6-month return
−33%
trailing
YTD return
−31%
this year
Relative strength
−41%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $10 › 200d $11 — 200d above 50d
Institutional flow
Accumulating
+2% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -29.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
61 holders — near 1-yr high, broad support
Squeeze score
18
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
24%
annualized · 1-yr
Max drawdown
−37%
past year
ATR
7.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−33%
Bearish
Price vs 50-day avg
−32%
Bearish
RSI (14)
11
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
Death cross
50d $10 › 200d $11 — 200d above 50d
Institutional flow
Accumulating
+2% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -29.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
61 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $7
Now $7 · 0%
Range high $11
vs 200-day avg -33%
vs 50-day avg -32%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ATII
this stock
Archimedes Tech SPAC Partners II Co.
|
$221.04M | -30.8% | — | — | 0.1% |
|
VYLR
Vylor Inc.
|
$48.80B | — | — | — | — |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$648.78M | +2.9% | — | — | 0.2% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$603.18M | +2.9% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
SEC Filings
Latest
8-K
- Filed
- Oct 13, 2026
- This year
- 11
Archimedes Tech SPAC Partners II Co. amended its subscription agreement so 7,031,175 of 10,000,000 subscribed shares become pre-funded warrants exercisable at $0.0001 each, and waived transfer restrictions on 3,000,000 shares transferred by the Sponsor to the Investor.
ViewEarnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ATII | -33.1% | -33.0% | -32.9% | -32.9% | -30.8% |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | -31.9% | -32.4% | -41.0% | -33.7% | -43.6% |